Blue Edge Capital LLC Increases Stock Holdings in Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO)
Blue Edge Capital LLC boosted its position in Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 295,859 shares of the exchange traded fund’s stock after purchasing an additional 2,579 shares during the period. Vanguard […]
More Stories
Rolls-Royce Holdings plc (LON:RR) Receives GBX 416.25 Average Target Price from Brokerages
Shares of Rolls-Royce Holdings plc (LON:RR – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Antofagasta plc (LON:ANTO) Given Average Recommendation of “Hold” by Brokerages
Antofagasta plc (LON:ANTO – Get Free Report) has been assigned a consensus rating of “Hold” from the seven research firms...
Brokerages Set Viking Therapeutics, Inc. (NASDAQ:VKTX) PT at $111.78
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned an average recommendation of “Buy” from the...
Analysts Set Robert Half Inc. (NYSE:RHI) Price Target at $67.86
Robert Half Inc. (NYSE:RHI – Get Free Report) has earned an average rating of “Hold” from the seven brokerages that...
Manhattan Associates, Inc. (NASDAQ:MANH) Receives $257.43 Consensus Target Price from Brokerages
Shares of Manhattan Associates, Inc. (NASDAQ:MANH – Get Free Report) have been given a consensus rating of “Moderate Buy” by...
Brokerages Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages...